ASTM E2329-14
Standard Practice for Identification of Seized Drugs
- Standard No.
- ASTM E2329-14
- Release Date
- 2014
- Published By
- American Society for Testing and Materials (ASTM)
- Status
- Replace By
- ASTM E2329-17
- Latest
- ASTM E2329-17
- Scope
3.1 These are minimum requirements applicable to the identification of seized drugs.
3.1.1 As these are minimum requirements, it should be recognized that they may not be sufficient for the identification of all drugs in all circumstances. Within these requirements, it is up to the individual laboratory’s management to determine which combination of analytical techniques best satisfies the requirements of its jurisdiction.
3.2 Correct identification of a drug or chemical depends on the use of an analytical scheme based on validated methods (see Practice E2549) and the competence of the analyst. It is expected that in the absence of unforeseen error, an appropriate analytical scheme effectively results in no uncertainty in reported identifications (see Practice E2764).
3.3 This practice requires the use of multiple uncorrelated techniques. It does not discourage the use of any particular method within an analytical scheme. Unique requirements in different jurisdictions may dictate the actual practices followed by a particular laboratory.
1.1 This practice describes minimum criteria for the qualitative analysis (identification) of seized drugs.
1.2 Listed are a number of analytical techniques for the identification of seized drugs. These techniques are grouped on the basis of their discriminating power. Analytical schemes based on these groupings are described.
1.3 Additional information is found in Guides E1968, E1969, E2125, and E2548 and Practices E2326, E2327, E2549, and E2764.
1.4 This practice does not replace knowledge, skill, ability, experience, education or training and should be used in conjunction with professional judgment.
1.5 This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety and health practices and determine the applicability of regulatory limitations prior to use.
ASTM E2329-14 Referenced Document
- ASTM E1968 Standard Guide for Microcrystal Testing in the Forensic Analysis of Cocaine
- ASTM E1969 Standard Guide for Microcrystal Testing in the Forensic Analysis of Methamphetamine and Amphetamine
- ASTM E2125 Standard Practice for Microcrystal Testing in Forensic Analysis for Phencyclidine and Its Analogues
- ASTM E2326 Standard Practice for Education and Training of Seized-Drug Analysts
- ASTM E2327 Standard Practice for Quality Assurance of Laboratories Performing Seized-Drug Analysis*， 2024-04-20 Update
- ASTM E2548 Standard Guide for Sampling Seized Drugs for Qualitative and Quantitative Analysis*， 2024-04-20 Update
- ASTM E2549 Standard Practice for Validation of Seized-Drug Analytical Methods
- ASTM E2764 Standard Practice for Uncertainty Assessment in the Context of Seized-Drug Analysis
ASTM E2329-14 history
- 2017 ASTM E2329-17 Standard Practice for Identification of Seized Drugs
- 2014 ASTM E2329-14 Standard Practice for Identification of Seized Drugs
- 2010 ASTM E2329-10 Standard Practice for Identification of Seized Drugs
- 2009 ASTM E2329-09 Standard Practice for Identification of Seized Drugs
- 2004 ASTM E2329-04 Standard Practice for Identification of Seized Drugs
